Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
Κύριοι συγγραφείς: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Oxford University Press
2018
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
ανά: Wattanakul, T, κ.ά.
Έκδοση: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
ανά: Thanaporn Wattanakul, κ.ά.
Έκδοση: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
ανά: Chotsiri, P, κ.ά.
Έκδοση: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
ανά: Pukrittayakamee, S, κ.ά.
Έκδοση: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
ανά: Saito, M, κ.ά.
Έκδοση: (2018)